The Crosstalk Between Gut Inflammation And Gastrointestinal Disorders During Acute Pancreatitis

Zhen-Zhen Guo,Pu Wang,Zhi-Hui Yi,Zhi-Yin Huang,Cheng-Wei Tang
DOI: https://doi.org/10.2174/13816128113199990414
IF: 3.31
2014-01-01
Current Pharmaceutical Design
Abstract:The intestinal inflammation caused by intestinal ischemia reperfusion during acute pancreatitis (AP) often leads to multiple organ dysfunction and aggravation of acute pancreatitis. This review concerns up-date progress of the pathophysiology and molecular mechanism of the excessive production of gut-derived cytokines. The regulation effects of immuno-neuro-endocrine network for pancreatic necrosis are the basis for pharmacological therapeutic in AP. The translation from basic research to clinical trials for the prevention or treatment of severe acute pancreatitis (SAP) is of great value. Early enteral nutrition is necessary for the restitution, proliferation, and differentiation of the intestinal epithelial cells adjacent to the wounded area. Clearance of the excess intestinal bacteria and supplement of probiotics may be helpful to prevent bacterial translocation and infection of pancreas.
What problem does this paper attempt to address?